TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE
Cardiovascular diseases remain the most common cause of death in Russia. In real clinical practice doctors are more focused on the modification of other major risk factors rather than on the correction of dyslipidemia, or pay more attention to secondary prevention of cardiovascular diseases.Aim. To...
Main Authors: | V. A. Korneva, T. Yu. Kuznetsova, E. S. Karpova, K. I. Rupasova |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/140 |
Similar Items
-
Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council
by: M. V. Ezhov, et al.
Published: (2021-03-01) -
TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE
by: V. A. Korneva, et al.
Published: (2015-09-01) -
Anti-hyperlipidemic effect of mangosteen (Garcinia mangostana L.) peel extract in dyslipidemia-induced rats
by: Lusiana Darsono, et al.
Published: (2023-11-01) -
Modern possibilities of intensive treatment of dyslipidemia and gaps in its control: literature review
by: Vera N. Larina, et al.
Published: (2023-04-01) -
Dyslipidemia: A Narrative Review on Pharmacotherapy
by: Lucas Lentini Herling de Oliveira, et al.
Published: (2024-02-01)